• Home
  •  / Affinia Therapeutics

Affinia Therapeutics

OverviewSuggest Edit

Affinia Therapeutics is a biotech company. It develops transformative gene therapies for devastating diseases.
TypePrivate
Founded2019
HQWaltham, MA, USMap
Websiteaffiniatx.com

Recent NewsAll News

Latest Updates

Employees (est.) (May 2022)80
Cybersecurity ratingBMore
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background

Affinia Therapeutics Office Locations

Affinia Therapeutics has an office in Waltham
Waltham, MA, US (HQ)
43 Foundry Ave #120waltham
Show all (1)

Affinia Therapeutics Financials and Metrics

Summary Metrics

Founding Date

2019

Affinia Therapeutics total Funding

$60 m

Affinia Therapeutics latest funding size

$60 m

Time since last funding

2 years ago

Affinia Therapeutics investors

New Enterprise Associates, Atlas Venture, Partners Innovation Fund, Lonza Group, Alexandria Venture Investments, F-Prime Capital
Affinia Therapeutics's latest funding round in March 2020 was reported to be $60 m. In total, Affinia Therapeutics has raised $60 m
Show all financial metrics

Affinia Therapeutics Cybersecurity Score

Cybersecurity ratingPremium dataset

B

80/100

Learn more about our premium products
SecurityScorecard logo

Affinia Therapeutics Online and Social Media Presence

Affinia Therapeutics's Trends

Embed Graph

Affinia Therapeutics News and Updates

March 08, 2022

Affinia Therapeutics Strengthens Leadership Team with Appointment of Diana M. Brainard, M.D., to the Board of Directors

WALTHAM, Mass., March 08, 2022 (GLOBE NEWSWIRE) -- Affinia Therapeutics, an innovative gene therapy company with a proprietary platform for rationally-designed adeno-associated virus (AAV) gene therapies for rare and prevalent devastating diseases, today announced the appointment of Diana M. Brain…
December 14, 2021

Affinia Therapeutics Appoints Thomas Leggett as Chief Financial Officer

WALTHAM, Mass., Dec. 14, 2021 (GLOBE NEWSWIRE) -- Affinia Therapeutics, an innovative gene therapy company with a proprietary platform for rationally-designed adeno-associated virus (AAV) gene therapies for rare and prevalent devastating diseases, today announced the appointment of Thomas (Tommy) …
October 06, 2021

Affinia Therapeutics Appoints Carole Faig to Board of Directors

WALTHAM, Mass., Oct. 06, 2021 (GLOBE NEWSWIRE) -- Affinia Therapeutics, an innovative gene therapy company with a proprietary platform for rationally-designed adeno-associated virus (AAV) gene therapies for rare and prevalent devastating diseases, today announced the appointment of Carole Faig to …
September 08, 2021

Affinia Therapeutics Announces Indications for Lead Gene Therapy Programs to Advance the Treatment of Neurologic and Neuro-oncologic Diseases supported by Multi-Year Manufacturing Agreement with Lonza Group

WALTHAM, Mass., Sept. 08, 2021 (GLOBE NEWSWIRE) --  Affinia Therapeutics, an innovative gene therapy company with a proprietary platform for rationally-designed adeno-associated virus (AAV) capsids developing gene therapies for rare and prevalent devastating diseases, today announced the first two…
July 20, 2021

Affinia Therapeutics Announces Collaboration with the Institute of Molecular and Clinical Ophthalmology Basel (IOB) To Rationally Design Novel CNS Promoters for Gene Therapy

– Botond Roska, M.D., Ph.D., world-renowned scientist and Director at IOB and scientific co-founder of Affinia Therapeutics, will oversee collaboration –
May 13, 2021

Affinia Therapeutics Presents New Data and Updates on AAV Platform at American Society of Gene and Cell Therapy Annual Meeting

Data shows multiple vectors with superiority to AAV9 in CNS, systemic approaches to target muscle while detargeting liver, and improvements in manufacturability Data shows multiple vectors with superiority to AAV9 in CNS, systemic approaches to target muscle while detargeting liver, and improvements…
Show more

 Affinia Therapeutics Frequently Asked Questions

  • When was Affinia Therapeutics founded?

    Affinia Therapeutics was founded in 2019.

  • How many employees does Affinia Therapeutics have?

    Affinia Therapeutics has 80 employees.

  • Who are Affinia Therapeutics competitors?

    Competitors of Affinia Therapeutics include Oxford BioTherapeutics, MicrofluidX and Stealth BioTherapeutics.

  • Where is Affinia Therapeutics headquarters?

    Affinia Therapeutics headquarters is located at 43 Foundry Ave #120waltham, Waltham.

  • Where are Affinia Therapeutics offices?

    Affinia Therapeutics has an office in Waltham.

  • How many offices does Affinia Therapeutics have?

    Affinia Therapeutics has 1 office.